Skip to main content
. 2022 Oct 5;13:1002938. doi: 10.3389/fimmu.2022.1002938

Table 2.

Efficacy of malignant pleural effusion and target lesions.

Microparticles group (n = 40) Placebo group(n = 39)
Malignant pleural effusion
 ORR 82.50% 58.97%
Target lesions
 ORR 25.64% 20.51%
 DCR 97.44% 92.31%

ORR, objective response rate; DCR, disease control rate.